The diagnostics startup is developing a testing platform that uses digital imaging and signal processing for pathogen identification and susceptibility determination.

Last week, readers were most interested in a story about BD's plan to separate its Biosciences and Diagnostics Solutions business by the end of 2026.

Demand remains low, but lab stakeholders said the industry is significantly better prepared to meet a spike in H5N1 testing ...

NEW YORK — MRC Holland said on Thursday that its blood-based assay for Temple, Kagami-Ogata, and Russell-Silver syndromes has received certification under Europe's In Vitro Diagnostic Regulation (IVDR ...

Imagene's AI-based multigene panel for predicting non-small cell lung cancer biomarkers from biopsy images will be combined with Tempus' real-world data.

NEW YORK – Hologic officials said on Wednesday that M&A will be crucial to growing its business while expressing confidence that it has bolstered its skills at acquiring and integrating new assets.

The digital pathology software developer is raising funding that would help it to increase its headcount and support its Aiosyn Mitosis Breast application.

Total revenues were $3.33 billion, up from $3.03 billion in the same quarter last year and slightly above the consensus Wall Street estimate of $3.31 billion.

NEW YORK – Siemens Healthineers on Thursday said it posted a 1 percent rise in diagnostics adjusted revenues year over year for its fiscal first quarter while its overall revenues grew by 6 percent.

The Foundation Medicine next-generation sequencing-based panels use Fulgent's technology platform and will analyze genes associated with hereditary cancers.